Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives

Gallbladder carcinoma (GBC) is a rare malignancy, with an estimated 5-year survival rate of less than 5% in the case of advanced disease. Surgery is the only radical treatment for early stages, but its application and effectiveness depend on the depth of tumoral invasion. The extent of resection is...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassese, Gianluca, Han, Ho-Seong, Yoon, Yoo-Seok, Lee, Jun Suh, Cho, Jai Young, Lee, Hae-Won, Lee, Boram, Troisi, Roberto Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320561/
https://www.ncbi.nlm.nih.gov/pubmed/35885535
http://dx.doi.org/10.3390/diagnostics12071630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320561/
https://www.ncbi.nlm.nih.gov/pubmed/35885535
http://dx.doi.org/10.3390/diagnostics12071630

Ejemplares similares